Due to minimal rates of radiation-induced cancer deaths resulting from CT surveillance, even modest benefits experienced by patients with Hodgkins Lymphoma (HL) is enough to justify its use, according to results of a study published in the June issue of the American Journal of Roentgenology.

Patients with mild to moderate renal dysfunction are at low risk for nephropathy resulting from the administration of CT contrast agents, according to results of a study published in the June issue of the American Journal of Roentgenology.

Dual energy material composition is twice as precise as other interpretation techniques when it comes to breast density assessment, according to results of a new study published online May 29 in the journal Academic Radiology.

A pair of Carestream Touch Ultrasound Systems have received FDA 510(k) clearance and are now available in the U.S.

The American Society of Clinical Oncology (ASCO) today released a proposal to significantly improve the quality and affordability of care for cancer patients.

Researchers at Cedars-Sinai Medical Center in Los Angeles are working on a technique that could diagnose brain tumors and treat the cancer with a combination of an MRI “virtual biopsy” and nano-scale drugs. 

The Patient-Centered Outcomes Research Institute (PCORI) will contribute $11.8 million to fund a study evaluating the effectiveness of new proton beam therapy for treating breast cancer as part of the institute’s initiative to support pragmatic clinical studies.

Physicians and researchers are still unsure how or where Alzheimer disease begins in the brain, but a new study has found that white matter degeneration—detectable using diffusion tensor imaging (DTI)—could be a reliable biomarker for atypical variations of the brain disease. The results of the study were published online May 27 in the journal Radiology.